Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Cancer vaccines: from an immunology perspective
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Huimeng Yan, Jinyuan Huang, Yingying Li, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Unlocking cancer vaccine potential: What are the key factors?
Michael Grant, Lian Ni Lee, Senthil Chinnakannan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders
X Li, Yuanxin Liu, Jun Gui, et al.
Advanced Science (2024) Vol. 11, Iss. 41
Open Access | Times Cited: 3
Sliding-attention transformer neural architecture for predicting T cell receptor–antigen–human leucocyte antigen binding
Ziyan Feng, Jingyang Chen, Youlong Hai, et al.
Nature Machine Intelligence (2024)
Open Access | Times Cited: 3
Chitosan-Functionalized Nanobubbles for Precision Oncology: Advances in Targeted Cancer Therapeutics
Vivek Pandey, Tejasvi Pandey
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 3
Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia
Dyantha I. van der Lee, Eva M. Argiro, Sebastiaan N. J. Laan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Rejuvenation of Tumor‐Specific T Cells via Ultrahigh DAR Antibody‐Polymeric Imidazoquinoline Complexes: Coordinated Targeting of PDL1 and Efficient TLR7/8 Activation in Intratumoral Dendritic Cells
Hongyu Chu, Yuezhan Shan, Zongyu Liu, et al.
Advanced Materials (2025)
Closed Access
A carrier-free DNA nanoplatform for efficient three-in-one tumor therapy in vivo
Hong Wang, Xuehe Lu, Jing Fan, et al.
Nano Today (2025) Vol. 62, pp. 102734-102734
Closed Access
Ex vivo pre-activation shifts the in vivo differentiation of adoptively transferred CD8+ T cells in a melanoma model
Jinjin Lu, Jianjun Hu, Zhihe Zhao, et al.
Molecular Immunology (2025) Vol. 182, pp. 139-149
Closed Access
Applications of Intravital Imaging in Cancer Immunotherapy
Deqiang Deng, Tianli Hao, Lisen Lu, et al.
Bioengineering (2024) Vol. 11, Iss. 3, pp. 264-264
Open Access | Times Cited: 3
Rationale and design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A continuously updated clinical trial database of cancer immunotherapies
Kim Boesen, Julian Hirt, Pascal Düblin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The war between the immune system and the tumor - using immune biomarkers as tracers
Kai Yang, Rongrong Lu, Jie Mei, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Introduction to RNA Vaccines Post COVID-19
Thomas Kramps
Methods in molecular biology (2024), pp. 1-22
Closed Access | Times Cited: 2
Personalized cancer T-cell therapy takes the stage, mirroring vaccine success
Johanna Chiffelle, Alexandre Harari
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 8
Open Access | Times Cited: 2
WDR77 in Pan-Cancer: Revealing expression patterns, genetic insights, and functional roles across diverse tumor types, with a spotlight on colorectal cancer
Yan Wang, Qihui Wu, Jiaxin Liu, et al.
Translational Oncology (2024) Vol. 49, pp. 102089-102089
Open Access | Times Cited: 2
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
Dengxiong Li, Ruicheng Wu, Qingxin Yu, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 6, pp. 596-615
Open Access | Times Cited: 2
Elucidation of binding mechanism, affinity, and complex structure between mWT1 tumor‐associated antigen peptide and HLA‐A*24:02
Gert‐Jan Bekker, Nobutaka Numoto, Maki Kawasaki, et al.
Protein Science (2023) Vol. 32, Iss. 10
Open Access | Times Cited: 4
A novel neoadjuvant therapy for early-stage non-small cell lung cancer in a mouse model
Lanlin Zhang, Jiangyuan Du, Xianghua Wu
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1108-1117
Open Access | Times Cited: 1
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors
Jose Cabezas-Caballero, Anna Huhn, Mikhail A. Kutuzov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ultrasound-Activatable In Situ Vaccine for Enhanced Antigen Self- and Cross-Presentation to Overcome Cancer Immunotherapy Resistance
Ge Chen, Yongchao Wang, Lianfeng Mo, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20296-20312
Closed Access | Times Cited: 1
De novo functional discovery of peptide-MHC restricted CARs from recombinase-constructed large-diversity monoclonal T cell libraries
Zening Wang, Abhijit Sarkar, Xin Ge
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Leveraging spatial omics for the development of precision sarcoma treatments
Cui Tu, Arutha Kulasinghe, Andrew P. Barbour, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 134-144
Closed Access
A mass cytometry approach to track the evolution of T cell responses during infection and immunotherapy by paired T cell receptor repertoire and T cell differentiation state analysis
Jesse Garcia Castillo, Rachel DeBarge, Abigail Mende, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top